JCI Insight

JCI Insight is an open access journal published by the American Society for Clinical Investigation that reports biomedical and translational research, established in 2016 with a 2025 Journal Impact Factor of 6.8《JCI 洞察》（JCI Insight）是美国临床研究学会出版的开放获取期刊，发表生物医学与转化研究，2016 年创办，2025 年影响因子为 6.8

Scope

• The journal publishes biomedical research across disciplines该刊发表横跨各学科的生物医学研究
• Translational studies with clinical relevance are central具临床相关性的转化研究是核心
• Mechanistic studies of human disease are covered人类疾病的机制研究在其范围
• Immunology, metabolism, neuroscience and cancer are among recurring areas免疫学、代谢、神经科学与肿瘤是常见领域
• Studies using animal models and human samples are both published使用动物模型与人体样本的研究均在发表之列
• Negative and confirmatory findings of value are considered有价值的阴性结果与验证性结果亦被考虑

History

• The journal was launched in 2016 by the American Society for Clinical Investigation as an open access companion to the Journal of Clinical Investigation该刊 2016 年由美国临床研究学会创办，是《Journal of Clinical Investigation》的开放获取伙伴刊
• It is published continuously with free access to all content期刊连续出版，全部内容免费开放
• The journal is published by American Society for Clinical Investigation and appears biweekly, under electronic ISSN 2379-3708该刊由（American Society for Clinical Investigation）出版，按半月刊出版，电子 ISSN 为 2379-3708。-
• Its Journal Impact Factor was 8.315 in 2021 and reached 6.8 in 2025, with the reported series 6.8, 6.1, 9.484, 8.315其影响因子由 2025 年的 6.8、2024 年的 6.1、2022 年的 9.484、2021 年的 8.315 等年度数据构成，最新为 2025 年的 6.8。

Editors

• The journal is edited by physician-scientists under the society's publications programme期刊由该学会出版体系下的医师科学家编辑
• Manuscripts are peer reviewed, with single anonymous peer review reported by the Directory of Open Access Journals稿件经同行评审，（Directory of Open Access Journals）登记为单匿名评审。
• Publication is funded by an article processing charge of 5000 USD with waivers available出版由 5000 USD 的文章处理费支持，并设有减免政策。
• It is indexed in the Science Citation Index Expanded, PubMed and Scopus该刊被（Science Citation Index Expanded）、（PubMed）与（Scopus）收录。